3D Tissue Models

Biotechnology: Merck

Total Score People Score Events Score
18 18 11
Date Event Presentation Speakers
August 17, 2010 Production & Manufacturing of Vaccines After the License Approval - What Can Analytics Do? Robert D. Sitrin
February 1, 2010 4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE What Companies Look for in a Licensing Partner Susan P. Rohrer
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Strategies for a Competitive Biologics Portfolio Georg Feger
June 23, 2009 Viral Safety for BioLogics GMPviral detection by qPCR: how to achieve speed, reliability, Health Authority approval and automation in a high-tech environment Emiliano Toso
June 9, 2009 Cell and Tissue-Based Assays for HTS Data Analysis in RNAi High-Throughput Screens Xiaohua Douglas Zhang
Evaluation of Putative GPCR Antagonists Using the CellKey System David J. Bell, Department of Automated Biotechnology, Merck & Company David J. Bell
December 2, 2008 Vaccines Europe 1: Potential correlates of protection and immune monitoring for prophylactic vaccines against chronic viral infections Danilo Casimiro,
March 31, 2008 China 2008 Pharmaceutical R&D Summit Track I Discovery to PreClinical Development –Case studies of Licensing & Partnering in China Chairperson’s Opening Remarks Dr. Bharatt M. Chowrira
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Michael W. Washabaugh
Assessing Structure/Function Relationships :Assessing Product Potency & Related Characteristics of Gardasil,® a Recombinant HPV Vaccine (09:45-10:15) Michael W. Washabaugh
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) David Wohlpart
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:45-10:15) David Wohlpart
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) John P. Hennessey
Emerging Analytical Technologies (13:25-15:30) John P. Hennessey
Emerging Analytical Technologies: Chairperson's Remarks (13:25-13:30) John P. Hennessey
Process and Analytical Related Issues: Specifications - The Interface between Clinical, Analytical, and Process (16:00-16:30) Timothy , Schofield
Process and Analytical Related Issues (15:30-17:00) Timothy , Schofield
September 30, 2007 BioProcess International Conference & Exhibition Plenary Session : Keynote Presentations and Featured Discussion (14:00 - 18:00) Barry C. Buckland
Plenary Session ; Keynote Presentations and Featured Discussion : Future of Cell Line and Process Development Barry C. Buckland
Novel Process Development Strategies : Accelerating Process Development: Automation of Analytical Assays Peter DePhillips
Novel Process Development Strategies (13:45 - 17:00) Peter DePhillips
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) Keynote Session 2: Creating the IT Infrastructure to Enable Adaptive Clinical Development (16:00-16:45) Jerald S. Schindler
BRIDGING DISCOVERY/DEVELOPMENT AND IT (09:30-15:30) Lori Harmon, Vic Uebele
BRIDGING DISCOVERY/DEVELOPMENT AND IT: Making the Most of Limited Resources - Creation of a Merck-wide Biologics Database (11:00-11:45) Lori Harmon, Vic Uebele
September 26, 2007 EuroBio2007 (Sep 26th - 28th) RED BIOTECH (09:00 - 18:30) Bruno Permanne
RED BIOTECH: Highlights on early stage drug candidates in the field of Alzheimer’s disease. (11:00 - 12:30) Bruno Permanne
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.